Search hospitals > New York > Brooklyn
Maimonides Medical Center
Claim this profileBrooklyn, New York 11219
Global Leader in Cancer
Global Leader in Pain
Conducts research for Leukemia
Conducts research for Syndrome
Conducts research for Breast Cancer
237 reported clinical trials
24 medical researchers
Summary
Maimonides Medical Center is a medical facility located in Brooklyn, New York. This center is recognized for care of Cancer, Pain, Leukemia, Syndrome, Breast Cancer and other specialties. Maimonides Medical Center is involved with conducting 237 clinical trials across 443 conditions. There are 24 research doctors associated with this hospital, such as Mahmut Y. Celiker, Sergey Motov, MD, Deepan Singh, MD, and Kevin Becker.Area of expertise
1Cancer
Global LeaderStage II
Stage I
Stage IV
2Pain
Global LeaderTop PIs
Mahmut Y. CelikerMaimonides Medical Center4 years of reported clinical research
Studies Leukemia
Studies Lymphoblastic Leukemia-Lymphoma
19 reported clinical trials
55 drugs studied
Sergey Motov, MDMaimonides Medical Center1 year of reported clinical research
Studies Pain
Studies Acute Pain
9 reported clinical trials
12 drugs studied
Deepan Singh, MDMaimonides Medical Center1 year of reported clinical research
Studies Prader-Willi Syndrome
Studies Syndrome
7 reported clinical trials
9 drugs studied
Kevin BeckerMaimonides Medical Center9 years of reported clinical research
Studies Cancer
Studies Non-Small Cell Lung Cancer
5 reported clinical trials
12 drugs studied
Clinical Trials running at Maimonides Medical Center
Breast Cancer
Non-Small Cell Lung Cancer
Lung Cancer
Bladder Carcinoma
Bladder Cancer
Renal Cell Carcinoma
Cancer
Stroke
Ovarian Tumors
Germ Cell Tumors
Pembrolizumab
for Triple-Negative Breast Cancer
The phase III trial compares the effect of pembrolizumab to observation for the treatment of patients with early-stage triple-negative breast cancer who achieved a pathologic complete response after preoperative chemotherapy in combination with pembrolizumab. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. This trial may help researchers determine if observation will result in the same risk of cancer coming back as pembrolizumab after surgery in triple-negative breast cancer patients who achieve pathologic complete response after preoperative chemotherapy with pembrolizumab.
Recruiting2 awards Phase 319 criteria
Omitting Radiation Therapy
for Breast Cancer
The purpose of this study is to compare the effects on low risk breast cancer receiving usual care that includes regional radiation therapy, with receiving no regional radiation therapy. Researchers want to see if not giving this type of radiation treatment works as well at preventing breast cancer from coming back.
Recruiting2 awards Phase 319 criteria
Support Program
for Breast Cancer
This phase III trial compares an additional support program (text message reminders and/or telephone-based counseling) with usual care in making sure breast cancer patients take their endocrine therapy medication as prescribed (medication adherence). Medication adherence is how well patients take the medication as prescribed by their doctors, and good medical adherence is when patients take medications correctly. Poor medication adherence has been shown to be a serious barrier to effective treatment for hormone receptor positive breast cancer patients. Adding text message reminders and/or telephone-based counseling to usual care may increase the number of days that patients take their endocrine therapy medication as prescribed.
Recruiting2 awards Phase 34 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Maimonides Medical Center?
Maimonides Medical Center is a medical facility located in Brooklyn, New York. This center is recognized for care of Cancer, Pain, Leukemia, Syndrome, Breast Cancer and other specialties. Maimonides Medical Center is involved with conducting 237 clinical trials across 443 conditions. There are 24 research doctors associated with this hospital, such as Mahmut Y. Celiker, Sergey Motov, MD, Deepan Singh, MD, and Kevin Becker.